FLUORINE-18 ( DrugBank: Fluorine-18 )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
41	Giant cell arteritis	2

41. Giant cell arteritis

---

Clinical trials : 128 /  Drugs : 139 - (DrugBank : 36) / Drug target genes : 33 - Drug target pathways : 124

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-001019-26-NL (EUCTR)	26/02/2021	14/07/2020	Imaging of inflamed arteries in giant cell arteritis with a PET/CT scan.	[18F]fluor-PEG-folate PET/CT imaging in Giant Cell Arteritis.	giant cell arteritis;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]	Product Name: [18F]PEG-Folate INN or Proposed INN: Fluorine-18 Other descriptive name: FLUORINE-18	University Medical Center Groningen, Department of Rheumatology and Clinical Immunology	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	10	Phase 2	Netherlands
2	NCT03285945 (ClinicalTrials.gov)	October 2014	12/10/2016	FDG Uptake in Large-Vessel Giant Cell Arteritis After Short-term, High-Dose Steroid Treatment	Fluorine-18-fluorodeoxyglucose Uptake in Large-Vessel Giant Cell Arteritis After Short-term, High-Dose Steroid Treatment - A Diagnostic Window of Opportunity?	Giant Cell Arteritis	Drug: PET3;Drug: PET10	University of Aarhus	NULL	Completed	50 Years	N/A	All	24	N/A	Denmark